Integral Ad Science (NASDAQ:IAS) Price Target Lowered to $16.00 at Truist Financial

Integral Ad Science (NASDAQ:IAS) had its price objective lowered by Truist Financial from $18.00 to $16.00 in a research note published on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Other equities analysts have also issued reports about the company. Morgan Stanley raised their price target on Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 23rd. Oppenheimer reduced their target price on Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating for the company in a report on Wednesday. Barclays increased their price target on shares of Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Monday, August 5th. Craig Hallum reduced their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, Benchmark reiterated a “hold” rating on shares of Integral Ad Science in a research note on Monday, August 5th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, Integral Ad Science has a consensus rating of “Moderate Buy” and an average price target of $15.70.

Integral Ad Science Stock Down 6.1 %

Shares of NASDAQ IAS opened at $10.11 on Wednesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.76. The stock has a market capitalization of $1.64 billion, a PE ratio of 50.55, a P/E/G ratio of 1.46 and a beta of 1.52. Integral Ad Science has a one year low of $7.98 and a one year high of $17.53. The business’s fifty day moving average price is $11.09 and its 200-day moving average price is $10.47.

Integral Ad Science (NASDAQ:IAS) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. The business had revenue of $133.50 million for the quarter, compared to the consensus estimate of $138.06 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The company’s revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.09) earnings per share. On average, equities research analysts anticipate that Integral Ad Science will post 0.25 EPS for the current year.

Insider Activity

In other news, CFO Tania Secor sold 5,240 shares of the business’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $52,976.40. Following the completion of the sale, the chief financial officer now directly owns 248,223 shares in the company, valued at approximately $2,509,534.53. The trade was a 2.07 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Lisa Utzschneider sold 10,481 shares of the company’s stock in a transaction on Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $105,962.91. Following the completion of the sale, the chief executive officer now directly owns 239,709 shares of the company’s stock, valued at $2,423,457.99. This trade represents a 4.19 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 23,006 shares of company stock worth $240,296. 2.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Integral Ad Science

Several hedge funds have recently added to or reduced their stakes in the business. Point72 DIFC Ltd purchased a new position in shares of Integral Ad Science in the third quarter worth about $41,000. nVerses Capital LLC purchased a new position in Integral Ad Science in the 3rd quarter worth approximately $45,000. Ameritas Investment Partners Inc. lifted its position in Integral Ad Science by 40.1% in the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after purchasing an additional 1,924 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Integral Ad Science during the third quarter valued at approximately $106,000. Finally, Stoneridge Investment Partners LLC bought a new position in shares of Integral Ad Science in the third quarter worth approximately $125,000. 95.78% of the stock is owned by institutional investors.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.